Neurology · Clinical Calculator · TIA & Stroke Risk

ABCD² Score for TIA Post-TIA Early Stroke Risk

After a transient ischemic attack (TIA), the risk of a completed stroke is highest in the first days. The ABCD² score combines five bedside items — Age, Blood pressure, Clinical features, Duration, and Diabetes — to a total of 0–7 and stratifies 2-day, 7-day, and 90-day stroke risk. Use it to frame urgency, not to decide admission on its own.

Published: References: 2 Read time:

← All calculators & tools  ·  NIHSS →

Instructions
  1. Confirm the event meets the definition of a TIA: a transient episode of neurologic dysfunction caused by focal brain, spinal cord, or retinal ischemia, without acute infarction on imaging.
  2. Score each of the five items: Age, Blood pressure at first evaluation, Clinical features, Duration of symptoms, and Diabetes. The total and risk band update automatically.
  3. Read the stratified 2-day, 7-day, and 90-day stroke-risk estimates alongside the clinical story, vascular imaging, and cardiac work-up — do not use the total alone to decide admission or discharge.
  4. Admit or arrange urgent same-day outpatient evaluation per current AHA/ASA guidance; most patients with a confirmed TIA benefit from expedited imaging and secondary-prevention review whatever the ABCD² score.

All computation runs in your browser; no values are stored or transmitted.

When to Use

Use the ABCD² score in the first evaluation of a patient after a suspected transient ischemic attack (TIA), to describe early-stroke risk and prioritise the speed of work-up. The score was derived and validated in large cohorts to predict 2-day, 7-day, and 90-day stroke after TIA; it is best used alongside vascular imaging (carotid duplex or CT angiography), cardiac rhythm monitoring, and brain imaging rather than as a standalone admission rule.

✅

Appropriate population

Adults presenting after a transient focal neurologic deficit consistent with TIA, where a secondary-prevention pathway (vascular imaging, cardiac monitoring, statin and antithrombotic review) is being planned. Also useful for communicating urgency to receiving teams and families.

⚠️

When NOT to rely on it alone

ABCD² does not identify the cause of the TIA, does not rule out a high-risk carotid or cardiac source in low-scoring patients, and is not sensitive to patients with crescendo TIAs or persistent diffusion-weighted imaging changes. Contemporary AHA/ASA guidance favors admission or an expedited same-day outpatient pathway for all suspected TIAs — ABCD² alone should not drive admit-versus-discharge, and low scores never exclude a treatable large-vessel lesion.

Pearls & Pitfalls
💡

Use the FIRST blood pressure

Score the initial blood pressure at presentation, not a later value after treatment. The derivation cohort used the first recorded reading, and a treated normotensive reading underscores an at-risk patient. "Weakness" scores two points only when the deficit is unilateral motor weakness; speech disturbance without weakness scores one; any other symptom (sensory alone, dizziness alone) scores zero.

🔬

Pair with imaging — always

A low ABCD² does not exclude a high-grade carotid stenosis or intracranial large-vessel lesion. Obtain urgent carotid imaging and consider an MRI with diffusion sequences in every TIA pathway; a positive DWI makes the event a "tissue-defined" stroke rather than a TIA and changes management.

🚫

Pitfalls

(1) Dizziness, isolated vertigo, or confusion alone do not usually count as "weakness" or "speech disturbance" — do not inflate the clinical-features item. (2) Durations are mutually exclusive — do not double-count a long event. (3) The Wardlaw 2015 meta-analysis showed that routine use of ABCD² to decide admission missed important fractions of early strokes; use it to communicate urgency, not to filter who gets a work-up. (4) The score is weaker in young patients, in patients with crescendo TIAs, and in known atrial fibrillation — anticoagulation decisions should not depend on ABCD².

Why Use It

The ABCD² score is a simple, memorable bedside tool that quantifies early-stroke risk after a TIA. Two-day stroke rates rise from about 1% in low-scoring patients to about 8% in high-scoring patients, and a high score reliably escalates the perceived urgency of vascular imaging, cardiac monitoring, antiplatelet start, blood-pressure management, and statin initiation. It is understood by emergency teams, admitting services, and neurology consultants, and it provides defensible documentation of why a given TIA was treated as "high risk." The score is complementary to — not a substitute for — a structured TIA work-up.

ABCD² Score for TIA

Score each of the five items. The total (0–7) and stratified 2-day, 7-day, and 90-day stroke-risk estimates update automatically.

e.g. 60 years or older
e.g. 148/92 mm Hg
e.g. unilateral weakness
e.g. 15 minutes
e.g. yes, type 2
0
ABCD² total
0–7
Low risk
Risk band
per Johnston 2007
1.0% / 1.2% / 3.1%
2d / 7d / 90d stroke
derivation cohort

⚕ Johnston SC et al. Lancet. 2007;369(9558):283–292. ABCD² estimates post-TIA stroke risk; it does not establish the TIA's cause, does not substitute for vascular or cardiac imaging, and should not be used on its own to decide admission or discharge. For licensed clinicians; integrate with imaging, cardiac work-up, and current AHA/ASA guidance.

Next Steps

Treat the ABCD² total as a framing device for urgency, not a discharge rule.

  • Total 0–3 (low risk): 2-day stroke risk about 1.0%, 7-day about 1.2%, 90-day about 3.1%. Still complete an expedited same-day or next-day TIA pathway: brain imaging (MRI with DWI preferred), carotid imaging, ECG, consider prolonged rhythm monitoring, start or optimize antiplatelet and statin, control blood pressure.
  • Total 4–5 (moderate risk): 2-day stroke risk about 4.1%, 7-day about 5.9%, 90-day about 9.8%. Admission or a high-acuity same-day observation pathway is reasonable. Confirm large-vessel vasculature and cardiac rhythm; start dual antiplatelet therapy (aspirin + clopidogrel) where guideline criteria are met, and control blood pressure.
  • Total 6–7 (high risk): 2-day stroke risk about 8.1%, 7-day about 11.7%, 90-day about 17.8%. Admit for close observation and rapid vascular and cardiac work-up. Consider early dual antiplatelet therapy (per CHANCE / POINT trial eligibility) and urgent carotid intervention if a high-grade symptomatic stenosis is found.
  • For any score, document the NIHSS if a deficit is still present on arrival, and if imaging reveals intracerebral hemorrhage, use the ICH Score for severity grading.
Evidence & References

Scoring

ItemPoints
Age ≥ 60 years+1
Blood pressure ≥ 140/90 mm Hg at first evaluation+1
Clinical features — unilateral weakness+2
Clinical features — speech disturbance without weakness+1
Clinical features — other symptoms0
Duration ≥ 60 minutes+2
Duration 10–59 minutes+1
Duration < 10 minutes0
Diabetes mellitus+1
Total0–7

Stroke risk bands (Johnston 2007 derivation cohort)

TotalBand2-day7-day90-day
0–3Low1.0%1.2%3.1%
4–5Moderate4.1%5.9%9.8%
6–7High8.1%11.7%17.8%

The ABCD² score was derived from pooled data of four TIA cohorts and refined to improve prediction of 2-day stroke. The Wardlaw meta-analysis later showed that routine use of ABCD² alone to admit or discharge TIA patients missed meaningful fractions of early strokes, so current practice pairs ABCD² with a structured TIA work-up and treats all suspected TIAs as time-sensitive.

References

  1. Johnston, S. C., Rothwell, P. M., Nguyen-Huynh, M. N., Giles, M. F., Elkins, J. S., Bernstein, A. L., & Sidney, S. (2007). Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet, 369(9558), 283–292. doi:10.1016/S0140-6736(07)60150-0.
  2. Wardlaw, J. M., Brazzelli, M., Chappell, F. M., Miranda, H., Shuler, K., Sandercock, P. A. G., & Dennis, M. S. (2015). ABCD2 score and secondary stroke prevention: Meta-analysis and effect per 1,000 patients triaged. Neurology, 85(4), 373–380. doi:10.1212/WNL.0000000000001780.
Important: This calculator is an educational aid for licensed clinicians and does not replace an individualized TIA evaluation. The ABCD² score describes early-stroke risk after a TIA; it does not establish the cause of the event, does not substitute for vascular, cardiac, or brain imaging, and should not be used as a standalone rule to admit or discharge a patient. Always integrate the result with the clinical story, imaging, rhythm monitoring, and current AHA/ASA guidance and institutional pathways.
References 2 sources
  1. Johnston, S. C., Rothwell, P. M., Nguyen-Huynh, M. N., Giles, M. F., Elkins, J. S., Bernstein, A. L., & Sidney, S. (2007). Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet, 369(9558), 283–292. https://doi.org/10.1016/S0140-6736(07)60150-0
  2. Wardlaw, J. M., Brazzelli, M., Chappell, F. M., Miranda, H., Shuler, K., Sandercock, P. A. G., & Dennis, M. S. (2015). ABCD2 score and secondary stroke prevention: Meta-analysis and effect per 1,000 patients triaged. Neurology, 85(4), 373–380. https://doi.org/10.1212/WNL.0000000000001780
Dr. W Rivero, MD

W Rivero, MD, FPCP, DPSN

Specialist in Internal Medicine, Nephrology, and Clinical Nutrition. Practicing integrative and evidence-based nephrology across Quezon City, Pampanga, and Bulacan.

· Book an Appointment →

QR code — scan to save Dr. Rivero's contact info

Scan and save

All Calculators Related Guides